Evidence map›Paper›PMID 35334070›Full record

ArticleApplied biochemistry and biotechnology2022

MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression.

Yafu Zhou, Jianhua Yan, Huiguo Chen, Wenwu Zhou, Guohua Xiao, Haoyu Zou, Jinsong Yang

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Decoding Rho GTPase signalling networks in directed cell migration.Frontiers in cell and developmental biology · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yafu ZhouDepartment of Cardiac Thoracic Surgery, Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), No.61, Jiefang West Road, Furong District, Changsha, 410000, China.
Jianhua YanDepartment of Cardiac Thoracic Surgery, Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), No.61, Jiefang West Road, Furong District, Changsha, 410000, China.
Huiguo ChenDepartment of Cardiac Thoracic Surgery, Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), No.61, Jiefang West Road, Furong District, Changsha, 410000, China.
Wenwu ZhouDepartment of Cardiac Thoracic Surgery, Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), No.61, Jiefang West Road, Furong District, Changsha, 410000, China.
Guohua XiaoDepartment of Cardiac Thoracic Surgery, Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), No.61, Jiefang West Road, Furong District, Changsha, 410000, China.
Haoyu ZouDepartment of Cardiac Thoracic Surgery, Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), No.61, Jiefang West Road, Furong District, Changsha, 410000, China.
Jinsong YangDepartment of Cardiac Thoracic Surgery, Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), No.61, Jiefang West Road, Furong District, Changsha, 410000, China. yangjingsong_yjs@163.com.ORCID http://orcid.org/0000-0003-3652-8010
Hunan Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung squamous cell carcinoma (LUSC) is one subtype of non-small-cell lung cancer, whose pathogenesis has not been fully understood. Exploring molecular mechanisms of LUSC helps a lot with the development of LUSC novel therapy. Hence, our study aims to investigate novel molecular mechanisms. Differentially expressed miRNAs and mRNAs were acquired from The Cancer Genome Atlas database. A series of assays were applied to test cell functions, including qRT-PCR to analyze RND1 and miR-4652-5p expression, dual-luciferase reporter gene assay to verify the targeting relationship between these two genes, cell counting kit-8 and colony formation assays to evaluate the ability of LUSC cells to proliferate, transwell to examine the migratory and invasive abilities, and western blot to test expression of RND1 and cell adhesion-related proteins. RND1 was lowly expressed while miR-4652-5p was highly expressed in LUSC cells. The correlation between these two genes was significantly negative and miR-4652-5p could downregulate RND1 expression. Additionally, cellular function assays validated that RND1 suppressed LUSC cells to proliferate, migrate, and invade. Besides, this gene might also affect cell adhesion. Furthermore, rescue assay suggested that miR-4652-5p downregulated RND1 expression to promote the progression of LUSC cells. Together, miR-4652-5p targeted RND1 to modulate cell adhesion and the progression of LUSC cells.

Indexed as

Carcinoma, Non-Small-Cell LungCarcinoma, Squamous CellLung NeoplasmsMicroRNAsrho GTP-Binding ProteinsCell AdhesionCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticHumansLungMicroRNAsMIRN4652 microRNA, humanrho GTP-Binding ProteinsRND1 protein, humanLung squamous cell carcinomaMigration; InvasionmiR-4652-5pRND1

Identifiers

PMID35334070
OpenAlexW4220739987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.